USFDA flags Telangana unit of Aurobindo Pharma arm

The letter, issued on August 15, was later made public by the USFDA, which stated that there was failure to ensure the accuracy of data in records for both production and process simulations, i.e. media fills. Media fill is a microbiological test to help prevent contamination during drug production.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/NHPy18o
via IFTTT